Key facts
- It has raised $2.4M; the latest was Later Stage VC in Apr 2026.
- Notable investors include Tech Incubator Program for Startup, IBK Changgong, Enlight Ventures, Colopl Next, Naver D2 Startup Factory — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for N.CER
- ·The full record, as it builds
Funding rounds
No funding rounds for N.CER are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About N.CER
Developer of diagnostic systems designed to detect dementia. The company develops a medical device using olfactory response and near-infrared spectroscopy that screens out early dementia that is difficult to distinguish with the existing questionnaire or imaging method, enabling doctors to diagnose early dementia based on changes in brain blood flow during sensory stimulation.
- Sector
- Healthcare
- HQ
- Gwangju, South Korea
- Founded
- 2019
- Employees
- 6
- Website
- ncerebro-en.imweb.me/
- Ownership
- Privately Held (backing)
N.CER doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in N.CER shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on N.CER in its N-PORT filings yet. We sweep new filings monthly.